LUX-Lung 1 trial suggests benefit from afatinib* in lung cancer patients

At CPHI Frankfurt we spoke to Anne-Cecile Bayne, Global Science & Innovation Lead Pharma and Medical Nutrition, and Marc Hendriks, Vice President Strategy & Business Development, on their expertise in nitrosamines and business strategy at DSM Biomedica...

The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled. 

A compound found in magic mushrooms, psilocybin, could be used to treat mental health conditions and help patients suffering with severe depression, as shown by the results of the largest study of its kind to date.

UK-based CRO Quanticate is set to partner with Cancer Research UK for the launch of the DETERMINE study focused on testing a range of existing and approved drugs and therapies on rare cancers.

Both tests have been approved by the US regulator for in vitro diagnostic use  

The test can distinguish between monkeypox and other diseases that cause similar symptoms. 

As concern over the monkeypox outbreak continues to rise, we take a look at major developments from the first week of August.   

The latest episode in the CPHI Podcast Series dives into the world of novel excipients and explores their importance for innovative drug development.